<DOC>
	<DOC>NCT00664391</DOC>
	<brief_summary>The purpose of this study is to demonstrate the safety of the gynecological formulation in normal and usual usage condition of Dermacyd Breeze.</brief_summary>
	<brief_title>Safety Dermatological Evaluation: Acceptability With Gynecological Follow up - Dermacyd Breeze</brief_title>
	<detailed_description />
	<mesh_term>Dermatologic Agents</mesh_term>
	<criteria>Integral skin test in the region; Lactation or gestational risk or gestation; Use of Antiinflammatory or immunosuppression drugs 1 month before the study; Topical medication use at the region to be treated; Cutaneous disease or active gynecological disease which may interfere in study results; Personal history of allergic disease at the area to be treated; Allergic or atopic history; The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>February 2009</verification_date>
</DOC>